175 related articles for article (PubMed ID: 35197123)
1. Assessing lead time bias due to mammography screening on estimates of loss in life expectancy.
Syriopoulou E; Gasparini A; Humphreys K; Andersson TM
Breast Cancer Res; 2022 Feb; 24(1):15. PubMed ID: 35197123
[TBL] [Abstract][Full Text] [Related]
2. Assessment of lead-time bias in estimates of relative survival for breast cancer.
Andersson TM; Rutherford MJ; Humphreys K
Cancer Epidemiol; 2017 Feb; 46():50-56. PubMed ID: 28027488
[TBL] [Abstract][Full Text] [Related]
3. Reference-Adjusted Loss in Life Expectancy for Population-Based Cancer Patient Survival Comparisons-with an Application to Colon Cancer in Sweden.
Andersson TM; Rutherford MJ; Møller B; Lambert PC; Myklebust TÅ
Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1720-1726. PubMed ID: 35700010
[TBL] [Abstract][Full Text] [Related]
4. A method for evaluating breast cancer screening strategies using screen-preventable loss of life.
Carter KJ; Castro F; Morcos RN
PLoS One; 2020; 15(12):e0243113. PubMed ID: 33275605
[TBL] [Abstract][Full Text] [Related]
5. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
6. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
7. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
8. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
9. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first child.
Hellquist BN; Czene K; Hjälm A; Nyström L; Jonsson H
Cancer; 2015 Jan; 121(2):251-8. PubMed ID: 25242087
[TBL] [Abstract][Full Text] [Related]
11. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
Coldman A; Phillips N
CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
[TBL] [Abstract][Full Text] [Related]
12. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
13. Loss in life expectancy in patients with stage II-III cutaneous melanoma in Sweden: A population-based cohort study.
Vikström S; Syriopoulou E; Andersson TM; Eriksson H
J Am Acad Dermatol; 2024 May; 90(5):963-969. PubMed ID: 38218560
[TBL] [Abstract][Full Text] [Related]
14. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
Jonsson H; Nyström L; Törnberg S; Lenner P
J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness evaluation of mammography screening program in Taiwan: Adjusting different distributions of age and calendar year for real world data.
Lin CN; Lee KT; Chang SM; Wang JD
J Formos Med Assoc; 2022 Mar; 121(3):633-642. PubMed ID: 34246512
[TBL] [Abstract][Full Text] [Related]
16. Decision-Making Regarding Mammography Screening for Older Women.
Schonberg MA
J Am Geriatr Soc; 2016 Dec; 64(12):2413-2418. PubMed ID: 27917463
[TBL] [Abstract][Full Text] [Related]
17. Clarifying the debate on population-based screening for breast cancer with mammography: A systematic review of randomized controlled trials on mammography with Bayesian meta-analysis and causal model.
Chen TH; Yen AM; Fann JC; Gordon P; Chen SL; Chiu SY; Hsu CY; Chang KJ; Lee WC; Yeoh KG; Saito H; Promthet S; Hamashima C; Maidin A; Robinson F; Zhao LZ
Medicine (Baltimore); 2017 Jan; 96(3):e5684. PubMed ID: 28099330
[TBL] [Abstract][Full Text] [Related]
18. Continuous tumour growth models, lead time estimation and length bias in breast cancer screening studies.
Abrahamsson L; Isheden G; Czene K; Humphreys K
Stat Methods Med Res; 2020 Feb; 29(2):374-395. PubMed ID: 30854935
[TBL] [Abstract][Full Text] [Related]
19. Swiss Medical Board Mammography screening predictions for Switzerland: importance of time-periods.
de Koning HJ; Heijnsdijk EA
J Med Screen; 2015 Dec; 22(4):201-6. PubMed ID: 26018779
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]